Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Alliacense announced today a wave of new MMP™ Portfolio licensees

hundreds of companies have been awaiting the outcome of US’336 and are now reengaging in licensing discussions in light of the escalating royalty rate structure of the MMP Portfolio™ Licensing Program.

Steve

Share
New Message
Please login to post a reply